Skip to main content
Log in

Thorotrast-induced ruptured hepatic angiosarcoma

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

The use of Thorotrast as a contrast medium is now of historical interest. Thorotrast-induced angiosarcoma, though rare, still generates considerable clinical interest because of the characteristic opacification of the liver, spleen, and lymph nodes, and the long latency period between exposure and the onset of the tumor. We present a case of hepatic angiosarcoma which developed 37 years after the administration of Thorotrast.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carrigan RH Manufacture of thorium dioxide suspension (Thorotrast). Ann NY Acad Sci 1967;145:530–532

    Google Scholar 

  2. Stover BJ. Effect of Thorotrast in humans. Health Phys 1983;44 (Suppl 1):253–257

    Google Scholar 

  3. Dudley RA. A survey of radiation dosimetry in thorium dioxide cases. NY Acad Sci 1967;145:595–607

    Google Scholar 

  4. Lightfoote JB, et al. CT appearance of reticuloendothelial thorotrast deposition with hepatic angiosarcoma. CT Clinical Symposium, 1984;7:1–3

    Google Scholar 

  5. Silverman PM, Ran PC, Korobkin M. CT appearance of abdominal thorotrast deposition and thorotrast induced angiosarcoma of the liver. J Comput Assist Tomogr 1983;7:655–658

    Google Scholar 

  6. Falk H, et al. Epidemiology of thorotrast induced hepatic angiosarcoma in the U.S. Env Res 1979;18:65–73

    Google Scholar 

  7. Winberg CD, Rauchod M. Thorotrast induced hepatic cholangiocarcinoma and angiosarcoma. Hum Pathol 1979;10:108–112

    Google Scholar 

  8. Abbott JD. History of the use and toxicity of thorotrast. Env Res 1979;18:6–12

    Google Scholar 

  9. MacMahon HE, Murphy AS, Bates MI. Endothelial cell sarcoma of the liver following thorotrast injections. Am J Pathol 1947;23:585–611

    Google Scholar 

  10. Underwood JC, Huck P. Thorotrast associated hepatic angio-sarcoma with 36 years latency. Cancer 1978;42:2610–2612

    Google Scholar 

  11. Alreuga DP. Primary angiosarcoma of the liver. Int Surg 1975;60:198–201

    Google Scholar 

  12. Kojiro M, Nakashima T, Ito Y, Ikezaki H, Mori T, et al. Thorium dioxide-related angiosarcoma of the liver. Arch Pathol Lab Med 1985;109:853–857

    Google Scholar 

  13. Manning JT Jr, Ordonez NG, Barton JH. Endothelial cell origin of the thorium dioxide-induced angiosarcoma of the liver. Arch Pathol Lab Med 1983;107:456–461

    Google Scholar 

  14. Dahlgren S. Thorotrast tumors-a review of the literature and report of two cases. Acta Pathol Microbiol Scand 1961;53:147–161

    Google Scholar 

  15. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical feature: of hepatic angiosarcoma; a report of four cases and a review of the English literature. Medicine 1979;58:48–64

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Azodo, M.V.U., Gutierrez, O.H. & Greer, T. Thorotrast-induced ruptured hepatic angiosarcoma. Abdom Imaging 18, 78–81 (1993). https://doi.org/10.1007/BF00201708

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00201708

Keywords

Navigation